Partners in Discovery
Partners in Discovery Spring 2009
Alternative Chloride Channels: CFTR isn’t the only kid on the block when it comes to chloride channels. ClC-2, pulmonologist Pam Zeitlin is finding, may provide a parallel pathway for chloride secretion.
Learn More About Partners in Discovery Spring 2009
Partners in Discovery Winter 2008
What is it in the genes and environment that really makes a difference? Why does one cystic fibrosis patient have only mild lung disease while another patient—with the same CFTR mutations—suffers severe lung disease? Are genes other than CFTR responsible for these variations? Or is the environment the cause?
Learn More About Partners in Discovery Winter 2008
Partners in Discovery Summer 2007
Pseudomonas aeruginosa is a nasty bug, infecting nearly 80 percent of all CF patients. And its success lies in part to its reputation for resisting many common antibiotics thrown at it. In fact, although immediate treatment with antibiotics can clear the infection, in many cases the bacteria adapt and establish permanent colonies in the lungs, increasing sputum production and decreasing lung function.
Learn More About Partners in Discovery Summer 2007
Partners in Discovery Fall 2006
A distinct advantage to being a patient of The Johns Hopkins Cystic Fibrosis Center is that the doctors you see regularly are contributing significantly to the understanding and management of cystic fibrosis worldwide.
Learn More About Partners in Discovery Fall 2006